Indian Healthcare Industry
|
|
- Oliver Shields
- 6 years ago
- Views:
Transcription
1 Indian Healthcare Industry 2012 Synopsis Disclaimer: All information contained in this report has been obtained from sources believed to be accurate by Gyan Research and Analytics Pvt. Ltd. (Gyan). While reasonable care has been taken in its preparation, Gyan makes no representation or warranty, express or implied, as to the accuracy, timeliness or completeness of any such information. The information contained herein may be changed without notice. All information should be considered solely as statements of opinion and Gyan will not be liable for any loss incurred by users from any use of the publication or contents.
2 Synopsis Buoyed by a congenial economic environment and demographic changes, the Indian healthcare industry has experienced exceptional growth over the past few years. In 2010, the industry was valued at USD 50 billion and was projected to grow at a healthy CAGR of 15 percent for the next five years. This momentum is expected to continue and place the sector at the top of the service sector players in India. Globally, the industry is amongst fastest growing sectors, with approximate revenues of USD 5.5 trillion in Within this context, India is viewed as one of the most promising markets among the developing countries and is projected to reach USD 140 billion by This report gives a comprehensive insight into the soaring Indian healthcare industry. It analyses the wide and diverse spectrum of Indian healthcare, with emphasis on opportunities in the areas of hospital infrastructure, pharmaceuticals, medical equipment, diagnostic labs and emerging fields like healthcare tourism, clinical trials & research and telemedicine. The overall industry scenario is upbeat, propelled by a growing economy, shifting demographics, rising disposable incomes, high incidence of lifestyle-induced diseases, new investment avenues and a large pool of talented and cost-effective human resource. The segments that are reaping the most benefits are hospitals, pharmaceuticals, medical equipment companies, pathological labs and other service providers, The Indian government, on its part, is promoting this sector through positive regulations like the introduction of the Health Bill, which proposes to bring all independent bodies like the Medical Council of India (MCI), the Dental Council of India (DCI), the Pharmacy Council of India (PCI) and the Nursing Council of India (NCI) under a centralized authority. The government is also increasing public expenditure on healthcare to 2.5 percent of GDP from 1 percent, encouraging public-private partnerships (PPP) in hospital infrastructure, and boosting medical tourism. Taking advantage of the prevalent optimistic atmosphere, many foreign players are looking to enter the country, especially in Tier-II and Tier-III cities, which have huge untapped markets. Meanwhile, the generic drugs market is set to expand, since most patents are going to expire in the next 5 years. Simultaneously, health cities and single specialty clinics are gaining prominence in 2 P a g e
3 promoting quality healthcare services at affordable prices. Health insurance portability is expected to increase the penetration of insurance by not only improving the quality of service levels, but also by raising competition among insurers to retain customers. Our report also profiles a few of the major players like Apollo Hospitals Group, Fortis Healthcare Group, and Ranbaxy Pharmaceuticals, among others. It looks at the financials of these companies in the context of key growth factors, thereby demonstrating the innate potential of the sector. The report aims to facilitate various international investors interested in the healthcare industry in India. Entrepreneurs who wish to set up hospitals and other components of the entire healthcare value chain and are contemplating entering into healthcare delivery may gain insight into the sector through this report. Interested players who plan to set up pharmaceutical companies, exporters and importers both in India and overseas, banks, industry researchers, analysts, financial institutes offering credit services to the sector, healthcare-related professionals and individual investors tracking different segments of healthcare industry in India may also find this report valuable. SCOPE OF THE REPORT Encompasses the entire healthcare manufacturing and services industry with their market size and share Opportunities in various segments of the industry Outlook of the industry KEY FEATURES DISCUSSED Indian & Global market outlook Growth drivers and trends of the industry Implications of the Union Budget on the industry Emerging fields and their growth trends Comparative Cost Advantage Key Investments and M&A activities in respective segments Export & Import of pharmaceuticals, healthcare products and medical equipment WHY ONE SHOULD BUY Comprehensive outlook of the industry Detailed analysis of all the segments and their opportunities has been discussed Better understanding of the market vis-à-vis market prospects Better positioning of products and service 3 P a g e
4 BENEFICIARIES OF THE REPORT Pharmaceutical Companies and Healthcare Service Providers Educational Institutes Business Research, KPO & Consulting companies Medical Equipment and Devices Manufacturers/Suppliers IT & ITES in Healthcare Sector Medical Practitioners & Clinical Trial Specialists Government and Policy Makers Commercial and Investment Banks Individuals/Investors 4 P a g e
5 Table of Contents 1. Executive Summary 2. Overview 2.1 Global Overview 2.2 Indian Overview 3. Indian Healthcare Industry 3.1 Market Size 3.2 Industry Structure 3.3 Market Segmentation and Trends Market Segmentation Major Trends Healthcare Manufacturing Pharmaceutical Industry Medical Equipment Healthcare-Services The Hospital Service Delivery Health Insurance Sector Diagnostic and Pathological Labs 3.4 Healthcare Infrastructure 3.5 Growth Drivers 3.6 Export-Import Export of Pharmaceutical Products 5 P a g e
6 3.6.2 Export of Medical Equipment Import of Pharmaceutical Products Import of Medical Equipment 4. Critical Success Factors 5. SWOT Analysis 6. Regulatory Norms, Taxes and Duties 6.1 Guidelines for the Pharmaceutical Industry 6.2 Guidelines for the Hospital Industry 6.3 Guidelines for Diagnostic and Pathological Laboratories 6.4 Guidelines for Medical Equipment 6.5 Taxes and Duties 7. Cost Structure 8. Issues and Challenges 9. Opportunities 10. Investments 10.1 Domestic 10.2 Foreign Direct Investment (FDI) 10.3 Private Equity Investments 10.4 Key Mergers and Acquisitions (M&A) 11. Major Players 12. Outlook 6 P a g e
7 List of Charts Chart 1 Historical Global Pharmaceutical Market Size Chart 2 - Forecast of Global Pharmaceutical Industry ( ) Chart 3 Comparison of Global Expenditure on Pharmaceuticals by Segments in 2010 & 2015 Chart 4 - Historical Indian Healthcare Market Size Chart 5 Forecast of Indian Healthcare Industry ( ) Chart 6 Segmentation of Indian Healthcare Market Chart 7 Comparison of Global Expenditure on Healthcare as a Percentage of GDP (2010) Chart 8 - Comparison of Global Healthcare Expenditure (2010) Chart 9 Comparison of Global Per Capita Healthcare Spending on PPP Basis Chart 10 Historical Indian Pharmaceutical Market Size Chart 11 - Forecast of Indian Pharmaceutical Industry ( ) Chart 12 - Segments of Indian Pharmaceutical Industry (2010) Chart 13 Historical Indian Medical Equipment Market Size Chart 14 - Forecast of Indian Medical Equipment ( ) Chart 15 - Historical Indian Hospitals Market Size Chart 16 - Forecast of Indian Hospitals Industry ( ) Chart 17 Historical Allocation of India's Health Budget Chart 18 - Health Insurance Premium (FY2006-FY2011) Chart 19 Segmentation of Health Expenditure in India Chart 20 - Indian Healthcare Delivery Structure Chart 21 - India's GDP Growth Rate Chart 22 - Indian Percentage Share in World GDP Chart 23 - BRIC s Population Growth Rate Chart 24 Prevalence of Lifestyle Diseases in India (2005 & 2015) 7 P a g e
8 Chart 25 Life Expectancy in India (in years) Chart 26 - Export of Pharmaceutical Products (FY2006-FY2011) Chart 27 - Export of Medical Equipment (FY2006-FY2011) Chart 28 - Import of Pharmaceutical Products (FY2006-FY2011) Chart 29 - Import of Medical Equipment (FY2006-FY2011) Chart 30 Forecast of Medical Tourism Market in India ( ) Chart 31 FDI Inflow in Healthcare in India (FY2006-FY2011) Chart 32 M&A Deals in Healthcare ( ) List of Figures Figure 1: Industry Indian Healthcare Industry Structure Figure 2: SWOT Analysis of Indian Healthcare List of Tables Table 1 - Top Five Drug Brands in the World by Sales Table 2 - Major Investments in Biotechnology in India Table 3 Details of Major Medical Equipment Companies in India Table 4 Market Drivers for Health Insurance in India Table 5 - Details of Major Pathological Labs in India Table 6 Comparison of Global Healthcare Infrastructure (2010) Table 7 - Healthcare Infrastructure Indicators in India Table 8 Comparative Cost Structure Table 9 - Comparison of Key Healthcare Procedure Costs Table 10 - Major PE Investments in Healthcare in India ( ) Table 11 Value of M&A Deals in Healthcare in India ( ) Table 12 - Major M&A Deals in Healthcare in India ( ) 8 P a g e
9 Table 13 Financials of Apollo Hospitals Group (FY2006- FY2011) Table 14 - Financials of Fortis Healthcare Group (FY2006- FY2011) Table 15 - Financials of Piramal Healthcare (FY2006- FY2011) Table 16- Financials of Ranbaxy Laboratories Ltd. (FY2006- FY2011) Table 17 - Financials of Dr. Reddy s Laboratories Ltd. (FY2006- FY2011) Table 18 - Financials of Sun Pharmaceuticals (FY2006- FY2011) 9 P a g e
IICCI Short Market Overviews. The Healthcare Industry in India
The Healthcare Industry in India 1. The Healthcare Industry In India healthcare is delivered through both the public sector and private sector. The public healthcare system consists of healthcare facilities
More informationSpan Diagnostics Limited
Span Diagnostics Limited Date: 5 th January, 216 Stock Performance Details Shareholding Details October 215 Current Price : ` 96.7^ Face Value : ` 1 per share 52 wk High / Low : ` 96.9 / 42.55 Total Traded
More informationGUFIC MANAGEMENT DISCUSSION AND ANALYSIS
GUFIC BIOSCIENCES LIMITED MANAGEMENT DISCUSSION AND ANALYSIS Indian Pharma Industry an overview The Indian Pharmaceutical industry has been witnessing phenomenal growth in recent years, driven by rising
More informationJenburkt Pharmaceuticals Limited
Jenburkt Pharmaceuticals Limited Date: 3 rd February, 2016 Stock Performance Details Shareholding Details October 2015 Current Price : ` 418.0^ Face Value : ` 10 per share 52 wk High / Low : ` 542.8 /
More informationIndian Pharmaceutical Formulations Industry Report,
Indian Pharmaceutical Formulations Industry Report, 2008-2009 India plays an important role in the global pharmaceutical market. In 2005, 2/5 DMFs to FDA were submitted by India. Currently, there are more
More informationReligare Technologies Ltd BSE Scrip Code:
Religare Technologies Ltd BSE Scrip Code: 533525 IT Consulting & Software October 15, 2012 Equity Statistics Current Market Price Rs. 17.05 52 Week High/Low Rs. 44.90/13.70 Market Capitalisation Rs. Crores
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 43.00 January 11, 2015 Stock Details BSE code 526301 BSE ID MEDINOV Face value ( ) 10 No of shares (m) 9 52 week
More informationHEALTHCARE AND MEDICAL EDUCATION
HEALTHCARE AND MEDICAL EDUCATION Contents Advantage Jharkhand Healthcare in India Health Indicators Healthcare in Jharkhand PPP-Success stories in Jharkhand Opportunity Landscape in Jharkhand Policy Interventions
More informationImpact on Education and Healthcare Sector Revenue from a 10% Increase in Broadband Penetration in India
Presentation for GSMA Impact on Education and Healthcare Sector Revenue from a 10% Increase in Broadband Penetration in India 20 May 2011 Ref: Contents 2 Approach and Results Summary Overview of Education
More informationPEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)
BUY CMP 1342.40 Target Price 1470.00 APOLLO HOSPITALS ENTERPRISE LTD Result Update (PARENT BASIS): Q3 FY15 MARCH 30 th 2015 ISIN: INE437A01024 Index Details Stock Data Sector Healthcare Facilities BSE
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 KMC Speciality Hospitals India Ltd CMP: 7.61 January 21, 2015 Stock Details BSE code 524520 BSE ID KMCSHIL Face value
More informationThe Brazil, Russia, India & China Over-the-Counter Pharmaceuticals Market to 2025 **SAMPLE**
The Brazil, Russia, India & China Over-the-Counter Pharmaceuticals Market to 2025 **SAMPLE** Pharmaceutical, commercial and strategic developments in the Brazil, Russia, India & China Over-the- Counter
More informationBird s Eye View of Indian Pharma
Bird s Eye View of Indian Pharma Classification of Pharma Industry Pharma industry Formulations Active Pharmaceuticals Ingredients Branded Generics Bulk drugs Pfizer Abbott GSK BMS Teva Mylan Dr Reddy
More informationTirupati Sarjan Limited
Tirupati Sarjan Limited Date: 5 th January, 216 Stock Performance Details Shareholding Details September 215 Current Price : ` 27.5^ Face Value : ` 5 per share 52 wk High / Low : ` 29.7 / 1.6 Total Traded
More informationNATCO PHARMA LTD. Result Update (PARENT BASIS): Q1 FY16
ISIN: INE987B01018 OCTOBER 15 th, 2015 STOCK DETAILS Sector NATCO PHARMA LTD. Result Update (PARENT BASIS): Q1 FY16 BSE Code 524816 Face Value 10.00 Pharmaceuticals 52wk. High / Low (Rs.) 2709.00/1245.40
More informationIndian Active Pharmaceutical Ingredients (APIs) Industry Report,
Indian Active Pharmaceutical Ingredients (APIs) Industry Report, 2008-2009 India plays an important part in the global API market. The API output value of India was US $4.1 billion in 2007, with the CAGR
More informationDr. Lal PathLabs Limited (DLPL) Q1 FY19 Results Presentation August 10, 2018
Dr. Lal PathLabs Limited (DLPL) Q1 FY19 Results Presentation August 10, 2018 Disclaimer By attending the meeting / telephonic call where this presentation is made, or by reading the presentation materials,
More informationAfrica Pharmaceutical
Africa Pharmaceutical (title Sector: ) Opportunities and Challenges Dr Feng Zhao Manager, Health Division Human Development Department, African Development Bank 1 The New Africa Economy Africa Rising:
More informationFIDSON HEALTHCARE PLC.
FIDSON HEALTHCARE PLC. EQUITY NIGERIA HEALTHCARE GTI Securities Research Coverage Analyst: Morolake Bisi-Afolabi Lead Analyst: Chuks Anyanwu c.anyanwu@gti.com.ng DECEMBER 15 th, 2015 Recommendation: BUY
More informationDr. Lal PathLabs Limited (DLPL) Q3 & 9M FY18 Results Presentation February 08, 2018
Dr. Lal PathLabs Limited (DLPL) Q3 & 9M FY18 Results Presentation February 08, 2018 Disclaimer By attending the meeting / telephonic call where this presentation is made, or by reading the presentation
More informationIndia: Great Expectations
India: Great Expectations Bangalore, India NEW CHINA: IMPACT OF THE CHINESE CONSUMER India: Great Expectations India is widely expected to be one of the fastest growing economies in the world despite
More informationHealthcare AUGUST For updated information, please visit
1 Contents Advantage India Market overview and trends Growth drivers Success stories: Apollo Hospitals, Fortis Opportunities Useful information 2 Advantage India Strong demand revenue in India is set to
More informationAlternative Investments Introduction To Real Estate Investments
Alternative Investments Introduction To Real Estate Investments Growth( %) India: Growth Engine of the World Economy India is the Seventh largest country in the world in terms of GDP and third largest
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Financial Performance Analysis of Sun Pharma. V Srinivasa Kumar*, R Renganathan, C Vijaya Banu, and V Vijaya Anand. Faculty at School
More informationThe Role of the Private Sector in Expanding Health Access to the Base of the Pyramid
The Role of the Private Sector in Expanding Health Access to the Base of the Pyramid ABOUT IFC IFC, a member of the World Bank Group, is the largest global development institution focused exclusively on
More informationBanking NOVEMBER For updated information, please visit
Banking NOVEMBER 1 Contents Advantage India Market overview and trends Growth drivers Success stories: HDFC, Axis Bank Opportunities Useful information 2 Banking NOVEMBER Advantage India Growing demand
More informationBUY AJANTA PHARMA LTD. CMP Target Price JAN. 28 th 2014 SYNOPSIS. Result Update: Q3 FY14
BUY CMP 940.00 Target Price 1025.00 AJANTA PHARMA LTD. Result Update: Q3 FY14 JAN. 28 th 2014 ISIN: INE031B01031 Index Details Stock Data Sector Pharmaceutical BSE Code 532331 Face Value 5.00 52wk. High
More informationM&A and Capital Raising Outlook S U R V E Y A survey by YES SECURITIES (INDIA) LIMITED, a wholly owned subsidiary of YES BANK LTD.
M&A and Capital Raising Outlook S U R V E Y 2 0 1 7 A survey by YES SECURITIES (INDIA) LIMITED, a wholly owned subsidiary of YES BANK LTD. M&A and Capital Raising OUTLOOK SURVEY 2017 Introduction Over
More informationIndia: Great Expectations
1 Emerging Market Experts Bangalore, India New China: Impact of The Chinese Consumer India is widely expected to be one of the fastest growing economies in the world despite challenges of poor infrastructure,
More informationLupin Investor Presentation Q3FY14
Lupin Investor Presentation Q3FY14 Vision: To be an innovation led transnational company Safe harbor statement Materials and information provided during this presentation may contain forward looking statements.
More informationThe Poliwogg BioPharma M&A Index
The Poliwogg BioPharma M&A Index Q4 2016 Industry Background Scientific Innovations Driving Opportunities: Increasing Understanding of Disease Mechanism Genomics Enabling Precision Medicine Better Therapeutics
More informationConstruction Chemicals Market India
Construction Chemicals Market India November 2014 Executive Summary Market Construction chemicals market stood at INR xx bn in and is expected to reach INR yy bn in, growing at a CAGR of about z% Growing
More informationUR Associates Research. Indian Radio Cab Market Challenges and Growth Opportunities. Sample Presentation
UR Associates Research Indian Radio Cab Market 2012 - Challenges and Growth Opportunities Indian radio cab market outlook A Sunrise Industry in India, Indian Radio Cab industry is characterized by huge
More informationMagellan Health: Innovating for Profitable Growth. Jefferies 2015 Healthcare Conference June 2, 2015
Magellan Health: Innovating for Profitable Growth Jefferies 2015 Healthcare Conference June 2, 2015 Cautionary Statement The schedules and statements made in this presentation include forward-looking statements
More informationWHY INDIA? CHAMPION SECTORS PROFILE INVESTMENT OPPORTUNITIES BUSINESS & REGULATORY ENVIRONMENT IN INDIA
SECTOR PROFILE 01 02 03 04 05 WHY INDIA? CHAMPION SECTORS PROFILE INVESTMENT OPPORTUNITIES BUSINESS & REGULATORY ENVIRONMENT IN INDIA 01 WHY INDIA? Focus on infrastructure development Large and growing
More informationToshihiko Osada General Manager, Strategic Planning Department. Corporate Strategy. Terumo Corporation Dec 12, 2016
2 Toshihiko Osada General Manager, Strategic Planning Department Corporate Strategy Outlook: Medtech Industry Global medtech market: Forecast to grow at a CAGR of 5-6% for the next 10 years, with market
More informationHigher FDI in Indian Insurance sector a buzz for the industry
Higher FDI in Indian Insurance sector a buzz for the industry The view from Transactions and Restructuring By Sam Evans, Global Insurance Transactions and Restructuring Lead, KPMG in Switzerland, Shashwat
More informationIndia: An Attractive Investment Destination. Department of Industrial Policy and Promotion Ministry of Commerce and Industry
India: An Attractive Investment Destination Department of Industrial Policy and Promotion Ministry of Commerce and Industry Indian economy: growth trajectory Indian economy at USD 4531 Billion (in PPP
More informationINDIAN TERRAIN FASHIONS LTD.(ITFL)
INDIAN TERRAIN FASHIONS LTD.(ITFL) Date :23 rd October, 2012 Stock Performance Details Background Current Price : Rs. 58.0** Face Value : Rs. 10 per share 52 wk High / Low : Rs. 127.00 / Rs. 47.65 Total
More informationAster DM Healthcare Ltd
IPO Note Healthcare Feb 08, 2018 Aster DM Healthcare Ltd Aster DM Healthcare Ltd (ADHL) is one of the largest private healthcare service providers which operates in multiple GCC states and is an emerging
More informationLeadership in life insurance. April 2008
Leadership in life insurance April 2008 Agenda Indian life insurance opportunity Organisational overview Performance highlights 2 Agenda Indian life insurance opportunity Organisational overview Performance
More informationRestile Ceramics Limited
Restile Ceramics Limited Date: 5 th January, 216 Stock Performance Details Shareholding Details September 215 Current Price : ` 8.63^ Face Value : ` 1 per share 52 wk High / Low : ` 1.44 / 2.57 Total Traded
More informationPersonal Accident and Health Insurance in India, Key Trends and Opportunities to 2018
Personal Accident and Health Insurance in India, Key Trends and Opportunities to 2018 Market Intelligence Report Reference code: IS0706MR Published: October 2014 www.timetric.com Timetric John Carpenter
More informationValue over volume The drivers of health care M&A in 2017
Value over volume The drivers of health care M&A in 2017 How to win in a thriving deal market Value over volume The drivers of health care M&A in 2017 Gregory Park Partner, US Health Transaction Advisory
More informationSigma Pharmaceuticals Limited
Investor Relations Contact: Gary Woodford Corporate Affairs Manager Gary.Woodford@signet.com.au Phone: 03 9215 9632 Mobile: 0417 399 204 Mark Hooper CEO and Managing Director Gary Woodford Corporate Affairs
More informationSmall-Cap Research. Atossa Genetics (ATOS-NASDAQ) ATOS: Zacks Company Report OUTLOOK
Small-Cap Research March 17, 2017 Grant Zeng, CFA 312-265-9466 gzeng@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Atossa Genetics (ATOS-NASDAQ) ATOS: Zacks Company Report ATOS: A pure
More informationGICS Consultation 2005
GICS Consultation 2005 Standard & Poor s and MSCI Consultation Paper on Potential Changes to the Global Industry Classification Standard (GICS ) Structure I. INTRODUCTION MSCI and Standard & Poor s (S&P),
More informationBUY SIMPLEX INFRASTRUCTURES LTD SYNOPSIS. CMP Target Price FEBRUARY 28 th Result Update (PARENT BASIS): Q3 FY15
BUY CMP 408.40 Target Price 460.00 SIMPLEX INFRASTRUCTURES LIMITED Result Update (PARENT BASIS): Q3 FY15 FEBRUARY 28 th 2015 ISIN: INE059B01024 Index Details Stock Data Sector Construction & Engineering
More informationFlorida Health Care Expenditures Report
Florida Health Care Expenditures Report 2015 Table of Contents Table of Contents... i Florida Health Care Expenditures in 2015... 1 Introduction... 1 Data and Methodology... 1 Findings... 2 Overall Trend...
More informationDr. Lal PathLabs Ltd.
Dr. Lal Pathlabs Ltd. (DLP) is a provider of diagnostic and related healthcare tests and services in India. It provides a range of diagnostic and related healthcare services which are used in core testing,
More informationWPS HealthyChoices Group Guide. Effective January 1, Be Happy. Live Healthy.
WPS HealthyChoices Group Guide Effective January 1, 2015 Be Happy. Live Healthy. Table of Contents: Introduction 2 Choose 4 Save 5 Control 6 Covered Benefits 7 2 With high-quality coverage, affordable
More informationNational Health Expenditure Accounts
National Health Expenditure Accounts Joe Benson, Devin Stone and The NHEA Team American Academy of Actuaries Webinar February 4, 2016 Overview National health spending reached $3.0 trillion, or $9,523
More informationCompany Overview. Financial Performance
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 CMP: 31.25 December 24, 2015 Stock Details BSE code 523878 BSE ID TOTEX Face value ( ) 10 No of shares (m) 8.1 Market
More informationSuper Sales India Limited
Super Sales India Limited Date: 20 th January, 2016 Stock Performance Details Shareholding Details September 2015 Current Price : ` 400.0^ Face Value : ` 10 per share 52 wk High / Low : ` 518.0 / 221.6
More informationCravatex Limited. Stock Performance Details Shareholding Details September 2015
Cravatex Limited Date: 20 th January, 2016 Stock Performance Details Shareholding Details September 2015 Current Price : ` 247.8^ Face Value : ` 10 per share 52 wk High / Low : ` 550.0 / 215.0 Total Traded
More information2008 REPORT. Agreement on the breast cancer test signed with SRL Ranbaxy. Indian multi-centre breast cancer study completed
Q2 28 REPORT 1ST HALF-YEAR HIGHLIGHTS: Agreement on the breast cancer test signed with SRL Ranbaxy Indian multi-centre breast cancer study completed NOK 44.8 million share issue European patent granted
More informationBDH Industries Limited BSE Scrip Code:
BDH Industries Limited BSE Scrip Code: 524828 Pharmaceuticals October 23, 2012 Equity Statistics Current Market Price Rs. 16.95 52 Week High/Low Rs. 21.00/13.15 Market Capitalisation Rs. Crores 9.76 Free
More informationSanofi India. CMP: INR2,200 TP: INR1,848 Neutral
BSE SENSEX S&P CNX 16,846 5,110 Bloomberg SANL IN Equity Shares (m) 23.0 52-Week Range (INR) 2,430/1,980 1,6,12 Rel. Perf. (%) 3/-3/15 M.Cap. (INR b) 50.7 M.Cap. (USD b) 0.9 26 July 2012 2QCY12 Results
More informationMergers & Acquisitions
Mergers & Acquisitions Shailesh Haribhakti 22 nd February, 2014 Overview of global M&A deals Global M&A activity in 2013 was flat (USD 2.22 trillion vs. USD 2.29 trillion in 2012). However H2 was relatively
More informationPredictive Analytics in the People s Republic of China
Predictive Analytics in the People s Republic of China Rong Yi, PhD Senior Consultant Rong.Yi@milliman.com Tel: 781.213.6200 4 th National Predictive Modeling Summit Arlington, VA September 15-16, 2010
More informationLucintel. Publisher Sample
Lucintel http://www.marketresearch.com/lucintel-v2747/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm EST Fridays: 5:30am
More informationFuture Trends in Employment, Health and Labor
Future Trends in Employment, Health and Labor PRESENTED BY: Mike Wojcik, MBA,CLU,CFP Senior Vice President Public Sector Practice Group The Horton Group www.thehortongroup.com 1 Agenda Affordable Care
More informationMACRO-ECONOMICS REGULATORY INFRASTRUCTURE PHARMA INDUSTRY
MACRO-ECONOMICS Economic growth are potentially good GDP per capita above $ 3.000 Government health budget increases to 5% Middle class category is projected into 150 Mn in 2014, average life expectancy
More informationA Prescription for Investing in Health Care
A Prescription for Investing in Health Care HEALTH CARE SECTOR REPORT 23 October 2017 ANALYST(S) Linda D Bannister, CFA John Boylan, CFA Ashtyn Evans, CFA John Nako Buy-rated companies mentioned in this
More informationScope of Practice & Compensation Report for the Regulatory Profession
2014 Scope of Practice & Compensation Report for the Regulatory Profession 2014 Scope of Practice & Compensation Report for the Regulatory Profession 1 Contents Introduction... 2 About RAPS... 2 The Survey:
More informationAvenue Supermarts Limited
IPO Note Retail March 4, 2017 Avenue Supermarts Limited A retailer with a growth appetite Avenue Supermarts Ltd (ASL), founded in 2002, is the owner of well established supermarket chain D-Mart. ASL is
More informationHEALTHCARE SERVICES QUARTERLY UPDATE Q4 2018
HEALTHCARE SERVICES QUARTERLY UPDATE Q4 2018 Transaction Value ($ Billions) 0.7 0.6 0.4 0.4 2.6 3.2 2.8 4.8 5.9 5.9 6.8 8.2 8.0 10.5 10.3 21.2 Transaction Volume (Number of Deals) INDUSTRY OVERVIEW M&A
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.07) Impressive Ex-US Sales Help ALIM Exceed Topline Expectations. ALIM recently announced
More informationPEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)
BUY CMP 1424.75 Target Price 1630.00 MINDTREE LIMITED Result Update (CONSO:IDATED BASIS): Q2 FY16 OCTOBER 17 th 2015 ISIN: INE018I01017 Index Details Stock Data Sector IT Consulting & Software BSE Code
More informationEmerging markets update Coloplast Capital Markets Day 2018 Kristian Villumsen, Executive Vice President, Chronic Care
Emerging markets update Coloplast Capital Markets Day 2018 Kristian Villumsen, Executive Vice President, Chronic Care Introducing Region Emerging Markets Region Emerging Markets at a glance Emerging Markets
More informationGeneral Corporate Criteria
16 General Corporate Criteria Rating Criteria Scope of the Criteria Lianhe Ratings Global Limited ( Lianhe Global ) applies the general corporate criteria to corporate entities that are not in the industry
More informationDoing Business With India
Doing Business With India Mahendra Pratap Entry India LLC mpratap@entryindia.com Australia June 3, 2011 Entry India LLC 1 USA Russia China Target Audience SMEs, Start-ups and Individuals Who want to Expand
More informationTwo fold growth in PE investments
INR, Billion INVESTMENT MARKETBEAT Two fold growth in PE investments INDIA Contents Foreign Direct Investment 1 Private Equity Investments in real estate 2 Investment Volume 2 Investment Type 2 City and
More informationLINCARE HOLDINGS INC.
LINCARE HOLDINGS INC. Forward-Looking Statements Certain statements contained in this presentation constitute forward-looking statements. Such forwardlooking statements are based on management s current
More informationGlance Finance Ltd. Other Financial Services. . Company Overview. Company Fundamentals. Key Strengths. CMP Rs BSE Code BSE ID
Other Financial Services Nov 15, 2012 CMP Rs. 19.55 BSE Code 531199 BSE ID GLANCE High/Low 1Y (Rs.) 35.15/ 16.55 Average Volume (3M) 279 Market Cap (Rs. Cr.) 6 Shareholding % Sep-12 Jun-12 Promoters 74.83
More informationThe Chinese Medtech Market
The Chinese Medtech Market 2017-2020 The Reimbursement System as one of the Key Drivers Authors: Helgert Van Raamt VP Partnerships and New Business Bart Van den Mooter CEO TforG Group PAGE 1 @ 2017 TFORG
More informationDIL Ltd. Pharmaceuticals. Company Overview. Company Fundamentals. CMP Rs
Pharmaceuticals September 26, 2012 CMP Rs. 700.4 BSE Code 506414 BSE ID DIL High/Low 1Y (Rs.) 748.2 / 373.9 Average Volume (3M) 579.8 Market Cap (Rs. Cr.) 161.1 Shareholding % Jun-12 Mar-12 Promoters 63.20
More informationConsulate General of India Durban. Trade and Investment Opportunities in India. Focus Area : Medical Tourism
Consulate General of India Durban Trade and Investment Opportunities in India Focus Area : Medical Tourism Economy $2.45 trillion economy. Economic Growth: 7.9% (2015-16); 7.1% in (2016-17) Sectoral contribution
More informationALEMBIC PHARMACEUTICALS LTD.(APL)
ALEMBIC PHARMACEUTICALS LTD.(APL) Date : 13 th September, 212 Stock Performance Details Current Price : Rs. 73.35** Face Value : Rs. 2 per share 52 wk High / Low : Rs. 78.95 / Rs.34. Total Traded Volumes
More informationHealthcare in China The Opportunity for Investment. Chindex International and United Family Healthcare February 2010
Healthcare in China The Opportunity for Investment Chindex International and United Family Healthcare February 2010 Forward Looking Statements This presentation contains information which may be considered
More informationA Study on GST Impact On Service Sectors With Special Reference To health Care In Mysore City
IOSR Journal of Business and Management (IOSR-JBM) e-issn: 2278-487X, p-issn: 2319-7668 PP 56-60 www.iosrjournals.org A Study on GST Impact On Service Sectors With Special Reference To health Care In Mysore
More informationNational Health Expenditure Projections
National Health Expenditure Projections 2011-2021 Forecast Summary In 2011, national health spending is estimated to have reached $2.7 trillion, growing at the same rate of 3.9 percent observed in 2010,
More informationOverview of Reimbursement Strategies for Novel Medical Technologies
Overview of Reimbursement Strategies for Novel Medical Technologies Nov 9, 2016 Goals and Objectives Develop understanding of U.S. medical technology reimbursement landscape and provide information about
More informationShifa International Hospitals Limited (Shifa)
Rating Report RATING REPORT Shifa International Hospitals Limited (Shifa) REPORT DATE: March 5, 2018 RATING ANALYSTS: Talha Iqbal talha.iqbal@jcrvis.com.pk Muhammad Ibad Desmukh ibad.deshmukh@jcrvis.com.pk
More informationPresenting Never Ending Consumption Story. Participate in One of the biggest consumption market of the World
Presenting Never Ending Consumption Story Participate in One of the biggest consumption market of the World 2 FY51 FY60 FY 70 FY 80 FY 90 FY 00 FY 05 FY 06 FY 07 FY 08 FY 09 FY 10 FY 11 FY 12 FY 13 FY
More informationINDIAN CAPITAL MARKET- BY ANMI (India)
INDIAN CAPITAL MARKET- BY ANMI (India) 1) ANMI is a pan India association comprising of the trading members across India like National Stock Exchange (NSE), Bombay Stock Exchange (BSE) and other exchanges
More informationReliance Capital Builder Fund II Series C (A Close Ended Equity Oriented Scheme)
Reliance Capital Builder Fund II Series C (A Close Ended Equity Oriented Scheme) Offer for Sale of Units at Rs.10/- per unit during the new fund offer period Tenure 3 years from the date of allotment of
More informationCOMPETITIVE POSITIONING OF THE TOP 10 PLAYERS GROWING ALLIANCES IN BIOPHARMACEUTICALS TABLE 7 KEY LICENSING AND PARTNERSHIP DEALS IN
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 2 INTENDED AUDIENCE... 3 METHODOLOGY AND INFORMATION SOURCES... 3 ANALYST CREDENTIALS...
More informationCompany Fundamentals
IT Software Products November 16, 2012 *CMP Rs.0.24 BSE Code 532403 BSE ID 4THGEN High/Low 1Y (Rs.) 0.62/0.22 Average Volume (3M) 6457 Market Cap (Rs. Cr.) 1 Shareholding % Sep-12 Jun-12 Promoters 15.32
More informationCampus Forum November 15, 2016 Agenda
Campus Forum November 15, 2016 Agenda Introductions MTIA Dedicated Team Current Plan Design Benchmarking Data Challenges and Considerations Specific Concerns Questions 2 M&T Insurance Agency, Inc. Dedicated
More informationSanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months
3QCY2017 Result Update Pharmaceutical November 20, 2017 Sanofi India Performance Highlights Y/E Dec. (` cr) 3QCY2017 2QCY2017 % chg (qoq) 3QCY2016 % chg (yoy) Net sales Other income Operating profit 627
More informationERM , Getzen Economics and Financing (Sec. 5.4, 5.5)
ERM 512-13, Getzen (Sec. 5.4, 5.5) 1/17 Key Points Types of Managed Care Plans Ways to Reduce Costs Features of Managed Care Utilization Review 2/17 Managed Care Plans Why Managed Care? Primary reason
More informationICICI Group: Performance & Strategy. November 2015
ICICI Group: Performance & Strategy November 2015 Certain statements in these slides are forward-looking statements. These statements are based on management's current expectations and are subject to uncertainty
More informationSanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.
2QCY2017 Result Update Pharmaceutical August 28, 2017 Sanofi India Performance Highlights Y/E Dec. (` cr) 2QCY2017 1QCY2017 % chg (qoq) 2QCY2016 % chg (yoy) Net sales Other income Operating profit 556
More informationReligare Invesco Caterpillar Portfolio. September 2015
Religare Invesco Caterpillar Portfolio September 2015 1 Favorable Demographics Increase in India s working population 50% 48.25% Young working population compared to peers Median age of the population,
More informationGeneral Insurance Industry in India
General Insurance Industry in India 2009 Casualty Loss Reserve Seminar September 14, 2009 Anita Sathe FCAS, FSA, MAAA ansathe@deloitte.com Contents History State of the market Removal of tariffs Key lines
More informationInvesting in Healthcare in Vietnam. KPMG Vietnam Webinar 30 November 2017
Investing in Healthcare in Vietnam KPMG Vietnam Webinar 30 November 2017 Investing in Healthcare in Vietnam Agenda 14:00-14:05 Introduction 14:05-14:15 Vietnam healthcare system at a glance 14:15-14:25
More informationBenefit proposal prepared for: Sample Proposal (3/17) PLANSTIN INC 5200 Meadows Rd Suite 150, Lake Oswego OR
Benefit proposal prepared for: Sample Proposal (3/17) 2017 PLANSTIN INC 5200 Meadows Rd Suite 150, Lake Oswego OR 97035 888-920-7526 BENEFIT SOLUTIONS Thank you for your consideration in the Planstin Benefit
More informationTHE FUTURE OF ROCKEFELLER INSIGHTS. David K. Song, M.D., Ph.D., CFA Senior Portfolio Manager and Managing Director
ROCKEFELLER INSIGHTS THE FUTURE OF H E A LT H C A R E David K. Song, M.D., Ph.D., CFA Senior Portfolio Manager and Managing Director Rolando Morillo Equity Analyst and Vice President R O C K C O.C O M
More informationHealthcare Sector The Stock Market SIM, Professor West. Yiping Yang, Lu Yu
Healthcare Sector The Stock Market SIM, Professor West Yiping Yang, Lu Yu 1 Agenda Sector Overview Business and Economic Analysis Financial Analysis Valuation Analysis Recommendation 2 Sector Overview
More information